Anixa Biosciences, Inc. (ANIX)
3.12
0.00 (0.00%)
USD |
NASDAQ |
Dec 31, 10:58
Anixa Biosciences EPS Diluted (Quarterly): -0.0695 for July 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Puma Biotechnology, Inc. | 0.1736 |
| GT Biopharma, Inc. | -0.8268 |
| Amneal Pharmaceuticals, Inc. | 0.0073 |
| Lexeo Therapeutics, Inc. | -0.3326 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.28M |
| Total Expenses (Quarterly) | 2.258M |
| Enterprise Value | 85.70M |
| Earnings Yield | -11.04% |
| Normalized Earnings Yield | -11.04 |